Content by Becton, Dickinson and Company
New solution supports injection of different viscosities and volumes without the need for system customization
New software version makes it easier for users to analyze multiple flow cytometry runs and compare data in a single view
BD MAX™ MDR-TB Panel obtains CE-IVD status in Europe
BD AbSeq is an assay that uses an oligo-conjugated antibody panel for protein cell-surface identification that can be added to RNA-seq single-cell experiments
The easy-to-use, browser-based application will help streamline workflows and automate manual processes
New cell sorter extends BD's robust portfolio of flow cytometry research solutions
BD Rhapsody™ single cell analysis system launches for gene expression profiling, plans to expand for protein analysis
New BD Phoenix™ M50 System delivers modularity, reliability, affordability, and high-quality susceptibility results needed by clinical microbiology laboratories worldwide
Sartorius Stedim Biotech, a leading international pharma and biotech supplier, and BD Diagnostics, a segment of BD (Becton, Dickinson and Company), a leading global medical technology company, today announced a collaboration to develop, manufacture and market various ready-to-use, prefilled media products for microbiological applications in pharmaceutical, biotech and research laboratories.
